Isolator and Filling Machine for Vials
groninger and SKAN have collaborated to develop Integra, a production line concept that integrates both an isolator and filling machine for vials with a large capacity range.
groninger and SKAN have collaborated to develop Integra, a production line concept that integrates both an isolator and filling machine for vials with a large capacity range.
The product was developed with a focus on processing toxic products. Features include shorter decontamination cycles and simplified cleaning. The integration of the filling machine into the isolator and the integration of the SKANFOG decontamination system allows the line to be cleaned and decontaminated in approximately 30 minutes with accessibility for operating personnel, according to groninger. Increased security and support for format changes enabled by the use of quick response codes gives operators a better overview of position, installation order, and recipe selection.
Different line configurations are available with either standardized open restricted access barrier systems or isolator modules and are capable of a maximum production output of 400 vials per minute, groninger reports.
Drug Solutions Podcast: Drug Packaging and Sustainability Essentials
April 4th 2023Lon Johnson, VP of Sales and Marketing at Colbert Packaging Corporation, discusses the latest drug packaging updates and how companies can become more sustainable with Pharmaceutical Technology editor Jill Murphy.
Drug Solutions Podcast: Processing Equipment Trends
November 1st 2022In this episode, Alivia Leon, assistant editor, speaks with Christian Dunne, director of global corporate business development, Chargepoint Technology, about current and future processing equipment trends, such as automation, cost, and sustainability.
Meeting Secondary Packaging Challenges of Innovative Delivery Systems for Biologics
February 6th 2025Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.
